Health
CRISPR-Cas9 Editing Can Favor Cancer-Linked KRAS Genes – Clinical OMICs News
Clinical trials based on CRISPR technology have been deferred due to potential risks, such as off-target effects, the creation…
Highlighting the need to monitor patients who have undergone CRISPR-Cas9-based gene therapy for cancer-related mutations, researchers at Sanford Burnham Prebys have shown that gene editing, specifically gene knockout (KO) using CRISPR-Cas9 technology, can…
Continue Reading
-
Noosa News12 hours agoTips to improve engagement – Proctor
-
Business16 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General22 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News15 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland